Browse > Article
http://dx.doi.org/10.3347/kjp.2015.53.2.169

Relationship between Antibody-Positive Rate against Plasmodium vivax Circumsporozoite Protein and Incidence of Malaria  

Lee, Hyeong-Woo (Department of Pathology, Immunology, and Laboratory Medicine, College of Medicine, University of Florida)
Kang, Yoon-Joong (Department of Biomedical Science, Jungwon University)
Cho, Shin-Hyeong (Division of Malaria and Parasitic Diseases, National Institute of Health, Korea Centers for Disease Control and Prevention)
Na, Byoung-Kuk (Department of Parasitology and Tropical Medicine and Institute of Health Sciences, Gyeongsang National University School of Medicine)
Pak, Jhang Ho (Asan Institute for Life Sciences, University of Ulsan College of Medicine Asan Medical Center)
Nam, Ho-Woo (Department of Parasitology, College of Medicine, Catholic University of Korea)
Park, Yun-Kyu (Department of Parasitology and Tropical Medicine and Inha Research Institute for Medical Sciences, Inha University School of Medicine)
Sohn, Youngjoo (Department of Anatomy, College of Korean Medicine, Institute of Korean Medicine, Kyung Hee University)
Kim, Tong-Soo (Department of Parasitology and Tropical Medicine and Inha Research Institute for Medical Sciences, Inha University School of Medicine)
Publication Information
Parasites, Hosts and Diseases / v.53, no.2, 2015 , pp. 169-175 More about this Journal
Abstract
The relationship between anti-Plasmodium vivax circumsporozoite protein (CSP) antibody levels and the prevalence of malaria in epidemic areas of South Korea was evaluated. Blood samples were collected from inhabitants of Gimpo-si (city), Paju-si, and Yeoncheon-gun (county) in Gyeonggi-do (province), as well as Cheorwon-gun in Gangwon-do from November to December 2004. Microscopic examinations were used to identify malaria parasites. ELISA was used to quantitate anti-circumsporozoite protein (CSP) antibodies against P. vivax. A total of 1,774 blood samples were collected. The overall CSP-ELISA-positive rate was 7.7% (n=139). The annual parasite incidences (APIs) in these areas gradually decreased from 2004 to 2005 (1.09 and 0.80, respectively). The positive rate in Gimpo (10.4%, 44/425) was the highest identified by CSP-ELISA. The highest API was found in Yeoncheon, followed by Cheorwon, Paju, and Gimpo in both years. The positive rates of CSP-ELISA were closely related to the APIs in the study areas. These results suggest that seroepidemiological studies based on CSP may be helpful in estimating the malaria prevalence in certain areas. In addition, this assay can be used to establish and evaluate malaria control and eradication programs in affected areas.
Keywords
Plasmodium vivax; annual parasite incidence; seropositivity; circumsporozoite protein;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Mendis K, Sina BJ, Marchesini P, Carter R. The neglected burden of Plasmodium vivax malaria. Am J Trop Med Hyg 2001; 64: 97-106.   DOI
2 Hasegawa Y. Malaria in Korea. Chosen Igakkai Zasshi 1913; 4: 53-69 (in Japanese).
3 National Malaria Eradication Service, Ministry of Health and Social Affairs, Republic of Korea. Malaria pre-eradication programme in Korea, 1961-1965. Progress Report. 1966, pp 44-70 (in Korean).
4 Paik YH, Rhee HI, Shim JC. Malaria in Korea. Jpn J Exp Med 1988; 58: 55-66.
5 Soh CT, Lee KT, Im KI, Min DY, Ahn MH, Kim JJ, Yong TS. Current status of malaria in Korea. Yonsei Rep Trop Med 1985; 16: 11-18.
6 Chai IH, Lim GI, Yoon SN, Oh WI, Kim SJ, Chai JY. Occurrence of tertian malaria in a male patient who has never been abroad. Korean J Parasitol 1994; 32: 195-200 (in Korean).   DOI
7 Cho SY, Kong Y, Park SM, Lee JS, Lim YA, Chae SL, Kho WG, Lee JS, Shim JC, Shin HK. Two vivax malaria cases detected in Korea. Korean J Parasitol 1994; 32: 281-284.   DOI
8 Lee JS, Kho WG, Lee HW, Seo M, Lee WJ. Current status of vivax malaria among civilians in Korea. Korean J Parasitol 1998; 36: 241-248.   DOI
9 Arnot DE, Barnwell JW, Tam JP, Nussenzweig V, Nussenzweig RS, Enea V. Circumsporozoite protein of Plasmodium vivax: gene cloning and characterization of the immunodominant epitope. Science 1985; 230: 815-818.   DOI
10 Lee HW, Lee JS, Lee WJ, Cho SH, Lee HS. The evaluation of recombinant circumsporozoite protein in malaria diagnosis. Korean J Microbiol 1999; 36: 142-149 (in Korean).
11 Cerutti C Jr, Boulos M, Coutinho AF, Hatab Mdo C, Falqueto A, Rezende HR, Duarte AM, Collins W, Malafronte RS. Epidemiologic aspects of the malaria transmission cycle in an area of very low incidence in Brazil. Malar J 2007; 6: 33.   DOI
12 Collins WE, Skinner JC. The indirect fluorescent antibody test for malaria. Am J Top Med Hyg 1972; 21: 690-695.   DOI
13 Wang DQ, Tang LH, Gu ZC, Zheng X, Yang MN. Application of the indirect fluorescent antibody assay in the study of malaria infection in the Yangtze River Three Gorges Reservoir, China. Malar J 2009; 8: 199.   DOI
14 Moody A. Rapid diagnostic tests for malaria parasites. Clin Microbiol Rev 2002; 15: 66-78.   DOI
15 McKenzie FE, Prudhomme WA, Magill AJ, Forney JR, Permpanich B, Lucas C, Gasser RA Jr, Wongsrichanalai C. White blood cell counts and malaria. J Infect Dis 2005; 192: 323-330.   DOI
16 Cohen J. Statistical power analysis for the behavioral sciences, 2nd ed. Psychology Press; 1988.
17 Kim KC. Preserving biodiversity in Korea's demilitarized zone. Science 1997; 278: 242-243.   DOI
18 Kho WG, Jang JY, Hong ST, Lee HW, Lee WJ, Lee JS. Border malaria characters of reemerging vivax malaria in the Republic of Korea. Korean J Parasitol 1999; 37: 71-76.   DOI
19 Shi YP, Alpers MP, Povoa MM, Lal AA. Diversity in the immunodominant determinants of the circumsporozoite protein of Plasmodium falciparum parasites from malaria endemic regions of Papua New Guinea and Brazil. Am J Trop Med Hyg 1992; 47: 844-851.   DOI
20 Webster HK, Boudreau EF, Pang LW, Permpanich B, Sookto P, Wirtz RA. Development of immunity in natural Plasmodium falciparum malaria: antibodies to the falciparum sporozoite vaccine 1 antigen (R32tet32). J Clin Microbiol 1987; 25: 1002-1008.
21 Snow RW, Gilles HM. The Anopheles vector. In Essential Malariology. 4th ed. London, UK. Arnold. 2002, p 59-84.